Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 067290185 approvals19 trials

JW SHINYAK CORPORATION

Official website

A pharmaceutical company supplying antifungal and urology drugs to clinics, co-marketing original drugs together with JW Pharmaceutical.

As of 2026-10-10, JW SHINYAK CORPORATION has 2 Korean MFDS device approvals, 183 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1981 and listed on KOSDAQ in 2003, JW Shinyak is a pharmaceutical company focused on manufacturing and selling medicines. It supplies antifungal agents and urology drugs to hospitals, clinics, and pharmacies, targeting the internal medicine market and clinic markets such as dermatology, pediatrics, urology, and otolaryngology, building its sales network through co-marketing of original drugs with JW Pharmaceutical. In 2025 it recorded consolidated revenue of KRW 81.0 billion and operating profit of KRW 7.5 billion, while its subsidiary JW Creagene completed liquidation on October 1, 2025.

Products & technology

  • Antifungal agentsFungal infection treatment
  • Urology drugsUrological disease treatment

Regulatory approvals

data.go.kr

183 Korean MFDS drug approvals · 1986–2026 / 2 Korean MFDS device approvals · 2004

  • MFDS drugPERAMIENZA Injection(Peramivir Hydrate)2026-09-02
    Drug · Prescription · Approval202602620
  • MFDS drugMinoxphase 2.5mg Tablet2026-02-27
    Drug · Prescription · Approval202600618
  • MFDS drugMinoxphase 5mg Tablet2026-02-11
    Drug · Prescription · Approval202600392
  • MFDS drugDORANEX Cap. (Tranexamic acid)2026-01-12
    Drug · Prescription · Approval202600108
  • MFDS drugESIPLE-N DUO Cap.2025-10-10
    Drug · OTC · Notification202502627
  • MFDS drugMYDIL 5% Foam Aerosol2024-08-02
    Drug · OTC · Notification202401884
  • MFDS drugEPINAIL topical solution (Efinaconazole)2024-07-08
    Drug · Prescription · Approval202401663
  • MFDS drugDecne Cream2024-06-28
    Drug · Prescription · Approval202401575
  • MFDS drugPD Tab. 2mg2023-11-21
    Drug · Prescription · Approval202303175
  • MFDS drugGinkgoturn Tab. 240mg2023-09-11
    Drug · OTC · Notification202302694
  • MFDS drugJADI-M DUO 12.5/500mg2023-09-01
    Drug · Prescription · Approval202302605
  • MFDS drugJADI-M DUO 12.5/1000mg2023-09-01
    Drug · Prescription · Approval202302606
Show 68 more
  • MFDS drugJADI-M DUO 12.5/850mg2023-09-01
    Drug · Prescription · Approval202302607
  • MFDS drugWilpower Focus Sol.2023-02-28
    Drug · OTC · Notification202300723
  • MFDS drugBestidine Tab. 40mg (Famotidine)2023-02-28
    Drug · Prescription · Approval202300724
  • MFDS drugDUALTERA Tablet 60/5mgRevoked2023-01-06
    Drug · Prescription · Approval202300094
  • MFDS drugDUALTERA Tablet 30/2.5mgRevoked2023-01-06
    Drug · Prescription · Approval202300134
  • MFDS drugIBUFEPHEN inj.2022-04-28
    Drug · Prescription · Approval202201731
  • MFDS drugJADI-M DUO Tab. 5/1000mg2022-04-04
    Drug · Prescription · Approval202201339
  • MFDS drugJADI-M DUO Tab. 5/850mg2022-04-04
    Drug · Prescription · Approval202201340
  • MFDS drugJADI-M DUO Tab. 5/500mg2022-04-04
    Drug · Prescription · Approval202201341
  • MFDS drugROCUDION Inj. (Sugammadex Sodium)2022-03-11
    Drug · Prescription · Approval202201035
  • MFDS drugBEBIUM Syrup. (Lactulose Concentrate)2022-01-13
    Drug · OTC · Notification202200245
  • MFDS drugBESDUO Tab. 20/800mg2021-06-18
    Drug · Prescription · Approval202104747
  • MFDS drugJADI-M Tab. 25mg (Empagliflozin)Revoked2021-03-05
    Drug · Prescription · Approval202102043
  • MFDS drugJADI-M Tab. 10mg(Empagliflozin)Revoked2021-03-05
    Drug · Prescription · Approval202102044
  • MFDS drugTAMIGA SR tab. (Mirabegron)2021-02-18
    Drug · Prescription · Approval202101475
  • MFDS drugAuszet tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101605
  • MFDS drugAuszet tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101606
  • MFDS drugAuszet tab. 10/40mg2021-02-18
    Drug · Prescription · Approval202101607
  • MFDS drugWELLMACO MINI soft cap. 2g (Omega-3-Acid Ethyl Esters 90)2020-03-11
    Drug · Prescription · Approval202001697
  • MFDS drugMONAKHAN Tab.2020-02-28
    Drug · Prescription · Approval202001433
  • MFDS drugJ Down Cap. 120mg2020-02-10
    Drug · Prescription · Approval202000759
  • MFDS drugJ Down Cap. 60mg2020-02-10
    Drug · Prescription · Approval202000760
  • MFDS drugGLICOVER Syrup (Choline Alfoscerate)Revoked2019-08-21
    Drug · Prescription · Notification201905919
  • MFDS drugBESTICON Soft Cap.Revoked2019-07-12
    Drug · Prescription · Notification201904711
  • MFDS drugJ-LETAL CR cap. 100mg (Cilostazol)Revoked2019-05-31
    Drug · Prescription · Approval201903651
  • MFDS drugJ-LETAL CR cap. 200mg (Cilostazol)Revoked2019-05-31
    Drug · Prescription · Approval201903652
  • MFDS drugPREFEPHEN Inj. (Acetaminophen)2019-05-21
    Drug · Prescription · Approval201903258
  • MFDS drugCEFANAN Tab. (Cefpodoxime Proxetil)2019-03-22
    Drug · Prescription · Approval201901723
  • MFDS drugJ.LOVA S tab. (Pelargonium Sidoides 11% Ethanol Dried Ext.(5.5~6.6→1))Revoked2018-08-28
    Drug · Prescription · Notification201803510
  • MFDS drugNEODART Tab. (Dutasteride)2018-07-04
    Drug · Prescription · Approval201802794
  • MFDS drugGLICOVER Tab. (Choline Alfoscerate)2018-06-27
    Drug · Prescription · Approval201802664
  • MFDS drugClocover Tab. (Clopidogrel Bisulfate)Revoked2018-05-30
    Drug · Prescription · Approval201802249
  • MFDS drugWELLMACO soft cap. (Omega-3-Acid Ethyl Esters 90)2018-03-23
    Drug · Prescription · Approval201801266
  • MFDS drugJW Shinyak Levosulpiride Tab. (Levosulpiride)2018-03-15
    Drug · Prescription · Approval201801180
  • MFDS drugJADE Tab. (R-Thioctic Acid Tromethamine)2018-01-29
    Drug · Prescription · Approval201800498
  • MFDS drugJ-FEROL Inj. (Cholecalciferol)2017-12-13
    Drug · Prescription · Notification201708339
  • MFDS drugJVASU Tab. 5mg2017-09-19
    Drug · Prescription · Approval201707146
  • MFDS drugJVASU Tab. 20mg2017-09-19
    Drug · Prescription · Approval201707147
  • MFDS drugJVASU Tab. 10mg2017-09-19
    Drug · Prescription · Approval201707148
  • MFDS drugHIBEPO Tab. 10mg (Bepotastine Besilate)2017-08-23
    Drug · Prescription · Approval201706789
  • MFDS drugCALLMEFLU Suspension Powder 6mg/mL (Oseltamivir Phosphate)2017-06-30
    Drug · Prescription · Approval201705153
  • MFDS drugBALGRIA Tab. 100mg (Sildenafil Citrate)2017-06-19
    Drug · Prescription · Approval201704021
  • MFDS drugBALGRIA Tab. 50mg (Sildenafil Citrate)2017-06-19
    Drug · Prescription · Approval201704022
  • MFDS drugBALGNAFIL Tab. 5mg (Tadalafil)2017-06-16
    Drug · Prescription · Approval201703977
  • MFDS drugBALGNAFIL Tab. 20mg (Tadalafil)Revoked2017-06-16
    Drug · Prescription · Approval201703978
  • MFDS drugBALGNAFIL Tab. 10mg (Tadalafil)Revoked2017-06-16
    Drug · Prescription · Approval201703979
  • MFDS drugNEOTUSS SR Tab. (Levodropropizine)2017-04-12
    Drug · Prescription · Approval201701834
  • MFDS drugJW ShinyakAtorvastatin Tab. 20mg2017-03-15
    Drug · Prescription · Approval201701286
  • MFDS drugJW ShinyakAtorvastatin Tab. 10mg2017-02-28
    Drug · Prescription · Approval201701097
  • MFDS drugCALLMEFLU Cap. 75mg (Oseltamivir Phosphate)2017-02-27
    Drug · Prescription · Approval201701049
  • MFDS drugTWYNTHERA tab. 40/5mg2016-09-30
    Drug · Prescription · Approval201605836
  • MFDS drugTWYNTHERA tab. 80/5mg2016-09-30
    Drug · Prescription · Approval201605837
  • MFDS drugTWYNTHERA tab. 40/10mg2016-09-30
    Drug · Prescription · Approval201605838
  • MFDS drugGLICOVER Soft Cap. (Choline Alfoscerate)2016-06-15
    Drug · Prescription · Approval201603465
  • MFDS drugJ-ryl Nail Lacquer (Amorolfine Hydrochloride)2016-05-11
    Drug · OTC · Notification201602591
  • MFDS drugEPINALE Tab. (Epinastine Hydrochloride)2016-05-04
    Drug · Prescription · Approval201602513
  • MFDS drugJ-COX Cap. 200mg (Celecoxib)Revoked2016-02-26
    Drug · Prescription · Approval201601082
  • MFDS drugESIPLE-N Cap. (Bacillus Licheniformis)2016-01-20
    Drug · OTC · Notification201600361
  • MFDS drugMONA S Cap.2015-11-25
    Drug · OTC · Notification201507900
  • MFDS drugNEXIALDI Tab. 20mg (Esomeprazole Magnesium Trihydrate)2015-10-30
    Drug · Prescription · Approval201507477
  • MFDS drugNEXIALDI Tab. 40mg (Esomeprazole Magnesium Trihydrate)2015-10-30
    Drug · Prescription · Approval201507478
  • MFDS drugRABEROSE Tab. 10mg (Rabeprazole Sodium)2015-10-15
    Drug · Prescription · Approval201507195
  • MFDS drugRABEROSE Tab. 20mg (Rabeprazole Sodium)2015-10-15
    Drug · Prescription · Approval201507196
  • MFDS drugTRIMACET SEMI Tab.2015-09-17
    Drug · Prescription · Approval201506598
  • MFDS drugXARIO OintmentRevoked2015-08-31
    Drug · Prescription · Approval201506191
  • MFDS drugTRIMACET Tab.2015-07-30
    Drug · Prescription · Approval201505164
  • MFDS drugMICARTELMI Tab. 40/12.5mg2015-06-08
    Drug · Prescription · Approval201503630
  • MFDS drugMICARTELMI Tab. 80/12.5mg2015-06-08
    Drug · Prescription · Approval201503631

Showing the 80 most recent of 185 records.

Clinical trials

data.go.kr

19 MFDS clinical trial authorisations · 2012–2024 (Bioequivalence 18 · Phase 1 1)

  • BioequivalenceJW06012024-06-27

    2 trial sites

  • BioequivalenceJW05012024-03-11

    2 trial sites

  • Phase 1JW01032023-09-27

    2 trial sites

  • BioequivalenceJW01032023-09-26

    2 trial sites

  • BioequivalenceJW04022023-03-10

    2 trial sites

  • BioequivalenceJW04012023-02-22

    2 trial sites

  • BioequivalenceJW01032022-06-28

    1 trial site

  • BioequivalenceJW01032022-06-24

    1 trial site

  • BioequivalenceHUC3-4702022-03-28

    1 trial site

  • Bioequivalence베스티딘정20밀리그램(파모티딘)2021-03-08

    2 trial sites

  • Bioequivalence피로이드정(피나스테리드)2020-08-11

    2 trial sites

  • Bioequivalence하이베포정10밀리그램(베포타스틴베실산염)2016-09-09

    2 trial sites

Show 7 more
  • Bioequivalence콜미플루캡슐75밀리그램(오셀타미비르인산염)2016-07-01

    2 trial sites

  • Bioequivalence레바큐어정(레바미피드)2014-05-27

    2 trial sites

  • Bioequivalence데소닉정0.2밀리그램(데소모프레신아세트산염)2013-12-27

    2 trial sites

  • Bioequivalence리스로마이신정(클래리트로마이신)2013-12-06

    2 trial sites

  • Bioequivalence제이더블유중외신약솔리페나신정10mg(솔리페나신숙신산염)(가칭)2013-10-29

    2 trial sites

  • Bioequivalence중외신약데스모프레신정0.2밀리그램(데스모프레신아세트산염)2012-12-20
  • Bioequivalence팜슈어정250밀리그람(팜시클로버)2012-11-01

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 49 more patents

AI reads

MAA server logs · IP-verified
77
Times AI engines pulled JW SHINYAK CORPORATION's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

76
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 1
Last 7 days
55
live 1
Last 30 days
77
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot67
  • GoogleGoogleOther4
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for JW SHINYAK CORPORATION and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

NUON CO., LTD.1 shared

KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.

HUONS CO., LTD.1 shared

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

YUNGJIN PHARM. CO., LTD1 shared

Founded in 1962 and listed on the KOSPI in 1973, Yungjin Pharm is a KT&G Group pharmaceutical affiliate exporting antibiotic injectables and APIs and operating a CMO business.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

DAE HWA PHARM CO., LTD1 shared

KOSDAQ-listed pharmaceutical company behind the world's first oral paclitaxel Liporaxel (DHP107) and the Amalian dermal filler.

JETEMA Co.,Ltd.1 shared

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

HANALL BIOPHARMA CO.,LTD1 shared

KOSPI-listed pharma/biotech company co-developing the autoimmune biologics batoclimab and imeropruvate with partner Immunovant.

Hironic Co.,Ltd1 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

PharmaResearch Co., Ltd.1 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

Humedix Co., Ltd.1 shared

KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.

DongKookPharmaceuticalCo.,Ltd.1 shared

KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.

CELLUMED CO., LTD.1 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition